Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 201

1.

Compounds that increase or mimic cyclic adenosine monophosphate enhance tristetraprolin degradation in lipopolysaccharide-treated murine j774 macrophages.

Jalonen U, Paukkeri EL, Moilanen E.

J Pharmacol Exp Ther. 2008 Aug;326(2):514-22. doi: 10.1124/jpet.107.133702. Epub 2008 May 9.

2.

Mitogen-activated protein kinase-activated protein kinase 2 regulates tumor necrosis factor mRNA stability and translation mainly by altering tristetraprolin expression, stability, and binding to adenine/uridine-rich element.

Hitti E, Iakovleva T, Brook M, Deppenmeier S, Gruber AD, Radzioch D, Clark AR, Blackshear PJ, Kotlyarov A, Gaestel M.

Mol Cell Biol. 2006 Mar;26(6):2399-407.

3.

Salbutamol increases tristetraprolin expression in macrophages.

Jalonen U, Leppänen T, Kankaanranta H, Moilanen E.

Life Sci. 2007 Dec 14;81(25-26):1651-8. Epub 2007 Oct 5.

PMID:
17964608
4.

The stability of tristetraprolin mRNA is regulated by mitogen-activated protein kinase p38 and by tristetraprolin itself.

Tchen CR, Brook M, Saklatvala J, Clark AR.

J Biol Chem. 2004 Jul 30;279(31):32393-400. Epub 2004 Jun 7.

5.

Tristetraprolin (TTP)-14-3-3 complex formation protects TTP from dephosphorylation by protein phosphatase 2a and stabilizes tumor necrosis factor-alpha mRNA.

Sun L, Stoecklin G, Van Way S, Hinkovska-Galcheva V, Guo RF, Anderson P, Shanley TP.

J Biol Chem. 2007 Feb 9;282(6):3766-77. Epub 2006 Dec 14.

7.

Differential regulation of ARE-mediated TNFalpha and IL-1beta mRNA stability by lipopolysaccharide in RAW264.7 cells.

Chen YL, Huang YL, Lin NY, Chen HC, Chiu WC, Chang CJ.

Biochem Biophys Res Commun. 2006 Jul 21;346(1):160-8. Epub 2006 May 24.

PMID:
16759646
8.

Inhibition of protein kinase Cdelta reduces tristetraprolin expression by destabilizing its mRNA in activated macrophages.

Leppänen T, Jalonen U, Korhonen R, Tuominen RK, Moilanen E.

Eur J Pharmacol. 2010 Feb 25;628(1-3):220-5. doi: 10.1016/j.ejphar.2009.11.014. Epub 2009 Nov 17.

PMID:
19925787
9.
10.

Butyrate suppresses tumor necrosis factor alpha production by regulating specific messenger RNA degradation mediated through a cis-acting AU-rich element.

Fukae J, Amasaki Y, Yamashita Y, Bohgaki T, Yasuda S, Jodo S, Atsumi T, Koike T.

Arthritis Rheum. 2005 Sep;52(9):2697-707.

11.

Gene transduction of tristetraprolin or its active domain reduces TNF-alpha production by Jurkat T cells.

Suzuki E, Tsutsumi A, Goto D, Matsumoto I, Ito S, Otsu M, Onodera M, Takahashi S, Sato Y, Sumida T.

Int J Mol Med. 2006 May;17(5):801-9.

PMID:
16596264
13.

Inhibition of tristetraprolin expression by dexamethasone in activated macrophages.

Jalonen U, Lahti A, Korhonen R, Kankaanranta H, Moilanen E.

Biochem Pharmacol. 2005 Mar 1;69(5):733-40. Epub 2005 Jan 21.

PMID:
15710351
14.

Inhibition of protein kinase C beta II downregulates tristetraprolin expression in activated macrophages.

Leppänen T, Jalonen U, Kankaanranta H, Tuominen R, Moilanen E.

Inflamm Res. 2008 May;57(5):230-40. doi: 10.1007/s00011-007-7122-2.

PMID:
18594783
15.
16.

Insulin increases tristetraprolin and decreases VEGF gene expression in mouse 3T3-L1 adipocytes.

Cao H, Urban JF Jr, Anderson RA.

Obesity (Silver Spring). 2008 Jun;16(6):1208-18. doi: 10.1038/oby.2008.65. Epub 2008 Apr 3.

18.

AU-rich element-mediated translational control: complexity and multiple activities of trans-activating factors.

Zhang T, Kruys V, Huez G, Gueydan C.

Biochem Soc Trans. 2002 Nov;30(Pt 6):952-8. Review.

PMID:
12440953
19.

Regulation of tumor necrosis factor expression in a macrophage-like cell line by lipopolysaccharide and cyclic AMP.

Taffet SM, Singhel KJ, Overholtzer JF, Shurtleff SA.

Cell Immunol. 1989 May;120(2):291-300.

PMID:
2541929
20.

Tristetraprolin regulates CXCL1 (KC) mRNA stability.

Datta S, Biswas R, Novotny M, Pavicic PG Jr, Herjan T, Mandal P, Hamilton TA.

J Immunol. 2008 Feb 15;180(4):2545-52.

Supplemental Content

Support Center